Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.69 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.61 |
| ▸ | FNTA | P49354 | 2/20 | 0.52 |
| ▸ | FNTB | P49356 | 2/20 | 0.52 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL560282 | 1.00 | ALDH1A1 (0.69) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL118465 | 1.00 | ALDH1A1 (0.69) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL1870463 | 1.00 | ALDH1A1 (0.69) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL118466 | 1.00 | ALDH1A1 (0.69) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL3851450 | 0.98 | ALDH1A1 (0.67) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL31509097 | 0.98 | ALDH1A1 (0.67) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL3502483 | 0.98 | ALDH1A1 (0.67) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| Acetic Acid SCHEMBL27783657 | 0.97 | ALDH1A1 (0.65) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| Butyric Acid SCHEMBL14763478 | 0.94 | ALDH1A1 (0.61) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL22833273 | 0.91 | ALDH1A1 (0.76) | ALDH1A1ALOX15TRPV1FNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2621462-A1 | ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR | The Procter and Gamble Company (US) | 2013-08-07 | — | — | EP | disclosed |
| EP-2496682-A1 | DELIVERY PARTICLE | The Procter & Gamble Company (US) | 2012-09-12 | — | — | EP | disclosed |
| WO-2012044728-A1 | ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR | THE PROCTER & GAMBLE COMPANY (US) | 2012-04-05 | — | — | WO | disclosed |
| WO-2011075556-A1 | COMPOSITION COMPRISING ENCAPSULATES, AND PROCESS FOR MAKING THEM | THE PROCTER & GAMBLE COMPANY (US) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011075551-A1 | PERFUMES AND PERFUME ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011056934-A1 | HIGH EFFICIENCY CAPSULES COMPRISING BENEFIT AGENT | THE PROCTER & GAMBLE COMPANY (US) | 2011-05-12 | — | — | WO | disclosed |
| WO-2011056935-A1 | DELIVERY PARTICLE | THE PROCTER & GAMBLE COMPANY (US) | 2011-05-12 | — | — | WO | disclosed |